Results 61 to 70 of about 60,559 (162)

ANGIOTENSIN CONVERTING ENZYME GEN POLIMORPHISM AND ITS RELATION WITH PLASMINOGEN ACTIVATOR INHIBITOR-1 IN CHRONIC DIALYSIS PATIENTS

Turkish Journal of Nephrology, 2019
It is well known that coronary events and changes in the fibrinolytic system are common complications seen in end stage renal disease (ESRD) patients. Previous studies have shown that the activities of the enzymes of fibrinolytic pathway differ between ...
İ. Çetin ÖZENER, Emel KARIŞIK, Azra BİHORAC, Mehmet KOÇ, Turgay İSPİR, Emel AKOĞLU   +5 more
doaj  

The Roles of Fibrinolytic Factors in Bone Destruction Caused by Inflammation

Cells
Chronic inflammatory diseases, such as rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, Crohn’s disease, periodontitis, and carcinoma metastasis frequently result in bone destruction.
Yosuke Kanno
doaj   +1 more source

Angiogenesis outcomes of metformin utilization in diabetes mellitus: a systematic review and meta-analysis

Journal of the Pakistan Medical Association
Objective: To review relevant literature regarding the role of metformin in angiogenesis among diabetic patients. Method: The systematic review and meta-analysis conducted from May to September 2022, and comprised search on Medline, ScienceDirect ...
Primasitha Maharani Harsoyo, Hanestya Oky Hermawan, Arisvia Sukma Hariftyani, Farah Aisha Shabrina, Anisya Dinda Paramitha, Saskia Ratna Desita, Yudi Her Oktaviono   +6 more
doaj   +1 more source

Plasminogen Activator Inhibitor 1 [PDF]

, 2020
openaire   +1 more source

Association of VTN Genotype with Plasminogen Activator Inhibitor-1 Activity in Late-Onset Alzheimer's Disease. [PDF]

Genes (Basel)
Agirbasli D, Agirbasli M, Cakir ME, Muftuoglu M.   +3 more
europepmc   +1 more source

Plasminogen activator inhibitor-1 as an oncologic target: biology, therapeutic inhibitors, and clinical translation. [PDF]

Front Oncol
Al Shaer NSH, Tleyjeh A, Al-Attas MA, Alibrahim JH, Khan MI, Yaqinuddin A.   +5 more
europepmc   +1 more source

Plasminogen Activator Inhibitor-1 is Internalized by Endothelial Cells via A Pinocytosis-Like Mechanism and Evades Degradation. [PDF]

FASEB J
McAdow M, Ahmetaj G, Hauschel R, Eichmann A, Sessa W.   +4 more
europepmc   +1 more source

Thermodynamics and selection of the plasminogen activator inhibitor-1 latency transition. [PDF]

J Biol Chem
Haynes LM, Holding ML, Woodard J, Siemieniak D, Ginsburg D.   +4 more
europepmc   +1 more source

A contemporary review of plasminogen activator inhibitor 1 in cardiovascular disease and broader disease state implications. [PDF]

Blood Vessel Thromb Hemost
Becerra M, Soogoor N, Vu J, Wortley J, Sathyamoorthy M.   +4 more
europepmc   +1 more source

Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Attenuates the Aggressive Phenotype of Vulvar Squamous Cell Carcinoma Cells <i>In Vitro</i>. [PDF]

In Vivo
Warmbold J, Gallwas J, Gründker C.
europepmc   +1 more source